Abstract:Purpose: A lipid-based, nanomicelle-loaded docetaxel (M-DOC) was designed and characterized. Optical imaging was employed to evaluate the pharmacokinetics and antitumor efficacy of docetaxel in vivo.Materials and methods: The M-DOC was prepared using the emulsion-diffusion method. Transmission electron microscopy and dynamic light scattering were used to assess the morphology and particle size of the M-DOC. Critical micelle concentrations, their stability under physiological conditions, and their encapsulation efficiency - as measured by high-performance liquid chromatography - were assessed. Pharmacological features were evaluated in two different animal models by comparing M-DOC treatments with docetaxel injections (I-DOC). Bioluminescence imaging was used to assess antitumor activity and docetaxel distribution in vivo, using nude mice injected with luciferase-expressing MDA-MB-231 human breast tumor cells. In addition, animals injected with B16 melanoma cells were used to measure survival time and docetaxel distribution.Results: The M-DOC was prepared as round, uniform spheres with an effective diameter of 20.8 nm. The critical micelle concentration of the original emulsion was 0.06%. Satisfactory encapsulation efficiency (87.6% +/- 3.0%) and 12-hour stability were achieved. Xenograft results demonstrated that the M-DOC was more effective in inhibiting tumor growth, without significantly changing body weight. Survival was prolonged by 12.6% in the M-DOC group. Tumor growth inhibitory rates in the M-DOC and I-DOC groups were 91.2% and 57.8% in volume and 71.8% and 44.9% in weight, respectively. Optical bioluminescence imaging of tumor growths yielded similar results. Area under the curve((0-6 hour)) levels of docetaxel in blood and tumors were significantly higher in the M-DOC group (15.9 +/- 3.2 mu g/mL(-1), 601.1 +/- 194.5 mu g/g(-1)) than in the I-DOC group (7.2 +/- 1.7 mu g/mL(-1), 357.8 +/- 86.2 mu g/g(-1)). The fluorescent dye 1,1-dioctadecyl-3,3,3,3'-tetramethylindotricarbocyanine iodide mimicked M-DOC in optical imaging, and accumulated more in tumors in comparison with I-DOC.Conclusion: These results suggest that the lipid-based nanomicelle system was effective in inhibiting tumor growth, with little toxicity. Moreover, we have developed a noninvasive optical imaging method for antitumor drug evaluation, which merits further analysis for potential clinical applications.

The Antitumor Effect of a New Docetaxel-Loaded Microbubble Combined with Low-Frequency Ultrasound in Vitro: Preparation and Parameter Analysis

Preparation and Antitumor Activity of Bfgf-Mediated Active Targeting Doxorubicin Microbubbles

Experiment on the Factors for Enhancing the Susceptibility of Cancer Cells to Chemotherapeutic Drug by Ultrasound Microbubbles.

The Effect of Docetaxel-Loaded Micro-Bubbles Combined with Low-Frequency Ultrasound in H22 Hepatocellular Carcinoma-Bearing Mice.

An Experimental Research into Endostatin Microbubble Combined with Focused Ultrasound for Anti-Tumor Angiogenesis in Colon Cancer

Bio-responsive Bletilla Striata Polysaccharide-Based Micelles for Enhancing Intracellular Docetaxel Delivery

Using acoustic cavitation to enhance chemotherapy of DOX liposomes: experiment in vitro and in vivo.

A Novel Chitosan Microbubble As Ultrasound-Triggered Drug Carrier for Antitumor in Vitro

Therapeutic ultrasound microbubbles carrying paclitaxel and LyP-1 peptide: Preparation, characterization and application to ultrasonic assisted chemotherapy in breast cancer cells

Therapeutic Ultrasonic Microbubbles Carrying Paclitaxel and LyP-1 Peptide: Preparation, Characterization and Application to Ultrasound-Assisted Chemotherapy in Breast Cancer Cells

The antitumor effect of novel docetaxel-loaded thermosensitive micelles.

Microbubbles-assisted Ultrasonication to Promote Tumor Accumulation of Therapeutics and Modulation of Tumor Microenvironment for Enhanced Cancer Treatments.

A Novel Lipid-Based Nanomicelle of Docetaxel: Evaluation of Antitumor Activity and Biodistribution

Ultrasound-Responsive Microfluidic Microbubbles For Combination Tumor Treatment

Microbubbles Enhance The Antitumor Effects Of Sinoporphyrin Sodium Mediated Sonodynamic Therapy Both In Vitro And In Vivo

PD-L1-targeted Microbubbles Loaded with Docetaxel Produce a Synergistic Effect for the Treatment of Lung Cancer under Ultrasound Irradiation

Enhanced Ultrasound Imaging and Anti-Tumor in Vivo Properties of Span–polyethylene Glycol with Folic Acid–carbon Nanotube–paclitaxel Multifunctional Microbubbles

Ultrasound Irradiation for Improvement of Antitumor Effects of Docetaxel Nanoparticles for Human Pancreatic Cancer Xenograft Nude Mouse Models

Advances in low-frequency ultrasound combined with microbubbles in targeted tumor therapy

Preparation of Drug-loaded Nanobubbles and Their Ultrasound-mediated Antitumor Effect

Targeting nanoparticle-conjugated microbubbles combined with ultrasound-mediated microbubble destruction for enhanced tumor therapy